The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
BRCAness in non-small cell lung cancer (NSCLC).
Saiama Naheed Waqar
No relevant relationships to disclose
Siddhartha H. K. Devarakonda
No relevant relationships to disclose
Loren S. Michel
No relevant relationships to disclose
Leonard B. Maggi
No relevant relationships to disclose
Mark Watson
No relevant relationships to disclose
Kalin Guebert
No relevant relationships to disclose
Danielle Carpenter
No relevant relationships to disclose
Barry P Sleckman
No relevant relationships to disclose
Ramaswamy Govindan
Consultant or Advisory Role - Bayer; Boehringer Ingelheim; Covidien; GlaxoSmithKline; Merck; Pfizer
Daniel Morgensztern
No relevant relationships to disclose